Financial statements Mw - Pharma
Balance sheet data of MW - PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 2 095 047,08 | 1 874 216,65 | 2 599 362,03 | 3 450 848,48 | 4 241 874,42 |
| A. Fixed assets | 273 370,46 | 86 981,12 | 54 485,84 | 55 996,23 | 71 955,35 |
| B. Current assets | 1 821 676,62 | 1 787 233,53 | 2 544 876,19 | 3 394 852,25 | 4 169 919,07 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 095 047,08 | 1 874 214,65 | 2 599 362,03 | 3 450 848,48 | 4 241 874,42 |
| A. Equity | 179 810,67 | 218 117,36 | 1 009 805,50 | 1 571 062,90 | 2 156 680,70 |
| B. Liabilities and provisions for liabilities | 1 915 236,41 | 1 656 097,29 | 1 589 556,53 | 1 879 785,58 | 2 085 193,72 |
| I. Long-term liabilities | 0,00 | 0,00 | 80 382,37 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 915 236,41 | 1 656 097,29 | 1 509 174,16 | 1 879 785,58 | 2 085 193,72 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.